Article content

Not all CBD is created equal.

New research to be presented at the American Academy of Neurology Annual Conference in Toronto in April finds artisanal CBD (Cannabidiol) is not as effective as pharmaceutical CBD when treating epilepsy patients.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Pharmaceutical CBD reduces seizures more than artisanal CBD: Study Back to video

“The difference was drastic, there was significant seizure control in the pharmaceutical group and worsening seizures in the artisanal group,” Dr. Nathan Cohen, one of the study’s authors, told The Toronto Sun.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or

” /]

The preliminary findings suggested pharmaceutical CBD led to a 39% reduction in seizures while artisanal CBD led to 70% increase in overall seizures.

There were 31 pediatric patients included in the retrospective study that had Lennox-Gastaut Syndrome (32%), Dravet Syndrome (6%) and other epilepsy syndromes (62%).